Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 116421 - 116440 out of 488784 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Croatia | (L01FC01) daratumumab | Darzalex | konc. za otop. za inf., boč. stakl. 1x100 mg/5 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagInternationalN.V. / JanssenBiologicsB.V |
| Croatia | (L01FC01) daratumumab | Darzalex | konc. za otop. za inf., boč. stakl. 1x400 mg/20 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagInternationalN.V. / JanssenBiologicsB.V |
| Croatia | (L01FC01) daratumumab | Darzalex | otop. za supkut. inj., boč. 1x1800 mg/15 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagInternationalN.V. / JanssenBiologicsB.V |
| Croatia | (L01FD01) trastuzumab | Herceptin | otop. za supkut. inj., boč. 1x600 mg/5 ml | Wholesale price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | RocheRegistrationGmbH / Roche |
| Croatia | (L01FD01) trastuzumab | Herceptin | boč. 1x150 mg | Wholesale price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | RocheRegistrationGmbH / Roche |
| Croatia | (L01FD01) trastuzumab | Herzuma | boč. 1x150 mg | Wholesale price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | CelltrionHealthcareHungaryKft. / BiotecServicesInternationalLtd |
| Croatia | (L01FD01) trastuzumab | Kanjinti | boč. 1x150 mg | Wholesale price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | AmgenEuropeB.V. / AmgenEuropeB.V. |
| Croatia | (L01FD01) trastuzumab | Ogivri | boč. 1x150 mg | Wholesale price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | ViatrisLimited / McDermottLaboratoriesLimitedT/AMylanDublinBiologics |
| Croatia | (L01FD01) trastuzumab | Trazimera | boč. 1x150 mg | Wholesale price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | PfizerEuropeMAEEIG / WyethPharmaceuticals,PfizerManufacturingBelgiumNV |
| Croatia | (L01FD01) trastuzumab | Zercepac | boč. 1x150 mg | Wholesale price with vat |
$0-0 |
$0-0 |
Breast Neoplasms; Stomach Neoplasms | AccordHealthcareS.L.U. / AccordHealthcareLimited,AccordHealthcarePolskaSp.zo.o. |
| Croatia | (L01FD01) trastuzumab | Kanjinti | boč. 1x420 mg | Wholesale price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | AmgenEuropeB.V. / AmgenEuropeB.V. |
| Croatia | (L01FD01) trastuzumab | Zercepac | boč. 1x420 mg | Wholesale price with vat |
$0-0 |
$0-0 |
Breast Neoplasms; Stomach Neoplasms | AccordHealthcareS.L.U. / AccordHealthcareLimited,AccordHealthcarePolskaSp.zo.o. |
| Croatia | (L01FD01) trastuzumab | Zercepac | boč. 1x60 mg | Wholesale price with vat |
$0-0 |
$0-0 |
Breast Neoplasms; Stomach Neoplasms | AccordHealthcareS.L.U. / AccordHealthcareLimited,AccordHealthcarePolskaSp.zo.o. |
| Croatia | (L01FD02) pertuzumab | Perjeta | konc. za otop. za inf., boč. stakl. 1x420 mg | Wholesale price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheRegistrationGmbH / RochePharmaAG |
| Croatia | (L01FD03) trastuzumab emtansine | Kadcyla | praš. za konc. za otop. za inf., boč. stakl. 1x100 mg | Wholesale price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheRegistrationGmbH / RochePharmaAG |
| Croatia | (L01FD03) trastuzumab emtansine | Kadcyla | praš. za konc. za otop. za inf., boč. stakl. 1x160 mg | Wholesale price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | RocheRegistrationGmbH / RochePharmaAG |
| Croatia | (L01FE02) panitumumab | Vectibix | konc. za otop. za inf., boč. 1x5 ml (20 mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Colorectal Neoplasms | AmgenEuropeB.V. / AmgenEuropeB.V. |
| Croatia | (L01FF01) nivolumab | Opdivo | konc. za otop. za inf., boč. stakl. 1x4 ml (10 mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Melanoma; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Urologic Neoplasms; Mesothelioma; Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG / Bristol-MyersSquibbS.r.l. |
| Croatia | (L01FF01) nivolumab | Opdivo | konc. za otop. za inf., boč. stakl. 1x10 ml (10 mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Melanoma; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Urologic Neoplasms; Mesothelioma; Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG / Bristol-MyersSquibbS.r.l. |
| Croatia | (L01FF01) nivolumab | Opdivo | konc. za otop. za inf., boč. stakl. 1x24 ml (10 mg/ml) | Wholesale price with vat |
$0-0 |
$0-0 |
Melanoma; Hodgkin Disease; Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Squamous Cell Carcinoma of Head and Neck; Urologic Neoplasms; Mesothelioma; Colorectal Neoplasms | Bristol-MyersSquibbPharmaEEIG / Bristol-MyersSquibbS.r.l. |
Pages
